NCT00134186View on ClinicalTrials.gov

Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

Not specified

Conditions
Carcinoma, Renal CellUrogenital NeoplasmsUrologic NeoplasmsKidney Neoplasms
Interventions
DRUG

motexafin gadolinium

Trial Locations (1)

77030

Methodist Hospital, Houston

Sponsors

Lead Sponsor

Pharmacyclics LLC.
All Listed Sponsors
lead

Pharmacyclics LLC.

INDUSTRY

NCT00134186 - Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer | Biotech Hunter | Biotech Hunter